Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide

• Main Authors: A. S. Ametov (Author), I. E. Shokhin (Author), E. A. Rogozhina (Author), T. G. Bodrova (Author), M. E. Nevretdinova (Author), P. A. Bely (Author), K. Ya. Zaslavskaya (Author), D. V. Kurkin (Author), K. N. Koryanova (Author), E. S. Mishchenko (Author), S. M. Noskov (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Liraglutide is one of the analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently a priority treatment for diseases such as type 2 diabetes mellitus (mono- and combination therapy), obesity and overweight in the presence of at least one concomitant disease.The aim of...